Article Details
Retrieved on: 2021-05-05 19:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... where we plan to combine with FDA-approved monoclonal antibodies targeting EGFR, HER2, and PDL1,” said Scott Wolchko, President and Chief ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here